Skip to search formSkip to main contentSkip to account menu

CI 775

Known as: CI-775 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

bevantolol

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
Effects of some cardioactive drugs on the oxygen affinity of whole blood.
Increasing amounts of Digoxin, Lasix, Teofyllamin and CI-775 were added to human blood in vitro and the whole blood oxygen… 
1986
1986
Pharmacokinetics and Concentration‐Effect Relationships of Bevantolol (CI‐775) in Normal Volunteers
The pharmacokinetic handling of the β, selective adrenoceptor blocking drug, bevantolol, was studied in 12 healthy volunteers… 
1979
1979
Comparative effects of cardioselective versus noncardioselective beta blockade on subendocardial blood flow and contractile function in ischemic myocardium.
1979
1979
Beneficial Actions of Bevantolol on Subendocardial Blood Flow and Contractile Function in Ischemic Myocardium
The effect of a new cardioselective beta adrenergic antagonist, bevantolol (CI-775), on regional myocardial blood flow and… 
1978
1978
Transmural triglycerides in acute myocardial ischaemia.
The effect of coronary artery occlusion on endogenous triglycerides of left ventricular subepicardium and subendocardium was… 
1977
1977
Pharmacologic evaluation of CI-775, a cardioselective beta adrenergic antagonist.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)